Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.

CONCLUSIONS: HZ/su reduces the risk of HZ-associated complications in older adults (NCT01165177; NCT01165229).
PMID: 29463421 [PubMed - as supplied by publisher]

Source: Vaccine - February 17, 2018 Category: Allergy & Immunology Authors: Kovac M, Lal H, Cunningham AL, Levin MJ, Johnson RW, Campora L, Volpi A, Heineman TC, ZOE-50/70 Study Group Tags: Vaccine Source Type: research